The Dying

Leslie Alan Horvitz

2014年7月 · Open Road Media

關於本電子書

The Spanish flu pandemic returns in this classic, chilling thriller of a dormant virus unleashed, a shocking conspiracy, and millions of lives at risk.

Danger lies frozen in the Alaskan wilderness, unnoticed by mankind, waiting to be released. A man’s corpse holds the remnants of a ferociously infectious disease that ravaged the globe at the end of World War I. Once the virus is set free again, a gruesome death awaits millions of unlucky victims. Everyone on Earth is susceptible—or so it seems. The followers of a mysterious religion possess an uncanny immunity to the illness, and a sinister intrigue unravels.
 
But before long, the insidious virus begins to mutate, daring the unwavering Dr. Lightman to keep up with it. Desperate to find a cure, he discovers that in order to stop the spread of the pandemic, it will be necessary to discover the human forces responsible.

關於作者

Leslie Alan Horvitz is the author of over twenty novels, including The Memory Hole, The Donors, Double Blinded, The Dying, and Causes Unknown. Editions of his books have been published in Germany, Poland, Hungary, Norway, Japan, Russia, South Korea, Brazil, and the United Kingdom. He is also the author of several works of nonfiction, most recently The Essential Book of Weather Folklore, The Encyclopedia of War Crimes and Genocide, The Weather Tracker, Night Sky Tracker Eureka: Scientific Breakthroughs That Changed the World, and Understanding Depression with Dr. Raymond DePaulo of Johns Hopkins University. In 1996 Horvitz collaborated with Dr. Joseph McCormick and his wife, Dr. Susan Fisher-Hoch, both noted epidemiologists, on Level 4: Virus Hunters of the CDC. “Level 4” refers to a biohazard unit in the Centers for Disease Control where scientists examine some of the most lethal pathogens known to man.
 
Horvitz has covered a variety of business, political, and social topics for general interest magazines including articles on money laundering, international organized crime, financial mergers, global trade, and fraud in biomedical research.